Mediation analyses hint that such injury explains some—but not all—of the gap in CV deaths between mAFP and standard care.
AI assistance can potentially cut turnaround times, which is increasingly important amid a rising burden of CVD.
TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...
SAN DIEGO, CA—Single closure with the Perclose ProGlide device (Abbott) after TAVI is noninferior to using two of the devices ...
The intervention was associated with better prosthesis fit as well as less HALT, but longer-term outcomes are needed.
With new IVL, balloon, and atherectomy data still coming fast, there’s not yet a “clear winner,” says Armando Pérez de Prado.
JACC has devoted an entire issue to the topic, with viewpoints, editorials, and estimated 5-year outcomes from the stopped ...
CHICAGO, IL— Sacubitril/valsartan shows promise as an antiarrhythmic agent among older patients with hypertension who are ...
Some continue to use it routinely, given data favoring clopidogrel monotherapy, but others struggle to see a future for this ...
CHICAGO, IL—For older adults who have chronic conditions but no known cardiovascular disease, quitting statins is no less ...
Patients had fewer MACE over 4 years compared with a standard systolic target, but some had worsened renal function.
Veterans aren’t “simply older adults that happen to have served in the military” but can benefit from tailored care and ...